Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review

BACKGROUND: Cancer and its therapies increase the risk of venous thromboembolism. Compared to patients without cancer, patients with cancer anticoagulated for venous thromboembolism are more likely to develop recurrent thrombotic events and major bleeding. Addressing all important outcomes including...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Akl, Elie A, Barba, Maddalena, Rohilla, Sandeep, Terrenato, Irene, Sperati, Francesca, Muti, Paola, Schünemann, Holger J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2008
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2507703/
https://ncbi.nlm.nih.gov/pubmed/18634550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-27-21
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki